Sponsor pipeline

Takeda clinical trial pipeline

Get alerts when Takeda's trials change

128 active trials 84 recruiting 45 Phase 3 19 disease areas 34 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days showing 28 of 34 changes on 19 trials

2026-09-04
Primary completion pushed: 2026-10-31 → 2027-10-31
Completion pushed: 2026-11-30 → 2027-10-31
NCT05067868 A Study of Replagal in Children and Adults With Fabry Disease in India · Phase 4
2026-08-28
Primary completion pushed: 2026-09-18 → 2027-02-17
NCT06233461 A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of… · Phase 2
2026-09-01
Enrollment reduced: 100 → 50 participants
NCT06045754 A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in… · Phase 4
2026-08-14
Enrollment reduced: 75 → 66 participants
Enrollment closed, study ongoing
NCT06677892 A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in…
2026-09-02
Enrollment closed, study ongoing
Final enrollment: 98 participants (planned 88)
NCT07363720 A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy · Phase 3
2026-09-02
Enrollment closed, study ongoing
Primary completion pushed: 2026-07-31 → 2026-09-30
Final enrollment: 402 participants (planned 100)
Completion pushed: 2026-07-31 → 2026-09-30
NCT07299097 Epidemiology of Narcolepsy Type 1 and Type 2 in Spain
2026-08-25
Recruitment opened
NCT07403968 A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease · Phase 2
2026-08-22
Trial completed
Enrollment increased: 10 → 28 participants
NCT06213974 A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV)…
2026-08-08
Trial completed
NCT05023382 A Study of Teduglutide in Japanese People With Short Bowel Syndrome
2026-08-08
Trial completed
NCT05626088 A Study in Adults With Inflammatory Bowel Disease (IBD) Receiving Vedolizumab in the…
2026-08-08
Primary completion pushed: 2026-09-30 → 2026-10-30
Completion pushed: 2026-09-30 → 2026-10-30
NCT07429942 A Study to Learn More About the Treatment of People With Congenital Thrombotic…
2026-08-22
Trial sites expanded: 1 → 13 locations
NCT07646678 A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia · Phase 2/3
2026-08-08
Trial sites expanded: 42 → 48 locations
NCT06980480 A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in… · Phase 3
2026-08-08
Trial sites expanded: 109 → 114 locations
NCT06948318 A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia · Phase 3
2026-08-08
Trial sites expanded: 114 → 123 locations
NCT06722235 A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia · Phase 3
2026-08-22
Trial sites expanded: 47 → 53 locations
NCT04419649 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk… · Phase 2
2026-08-15
Trial sites expanded: 1 → 60 locations
NCT07392450 A Study of TAK-755 in Adults With Acute Ischemic Stroke · Phase 2
2026-08-13
Trial sites reduced: 53 → 48 locations
NCT06045754 A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in… · Phase 4
2026-08-13
Trial sites reduced: 49 → 46 locations
NCT06095128 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) · Phase 4
2026-08-18
Primary completion moved earlier: 2026-09-30 → 2026-07-14
NCT06254950 A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of… · Phase 2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-08-31 NCT07794735 A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been… Phase 4 Not Yet Recruiting
2026-08-14 NCT07765602 A Study of Rusfertide in Adults With Polycythemia Vera in China Phase 2 Not Yet Recruiting
2026-08-07 NCT07752108 A Study of Zasocitinib in Adults With Non-pustular Palmoplantar Psoriasis Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
5
Phase 2
19
Phase 2/3
3
Phase 3
42
Phase 4
8
Not charted: 49 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 128

NCT IDTitleConditionStatusUpdated
Phase 4
NCT05067868 A Study of Replagal in Children and Adults With Fabry Disease in India Fabry Disease Recruiting 2026-09-03
NCT06045754 A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in… Crohn's Disease Recruiting 2026-08-31
NCT06581328 A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the… Ulcerative Colitis Recruiting 2026-08-14
NCT06095128 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) Ulcerative Colitis Recruiting 2026-08-12
NCT06562543 A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With… Colorectal Cancer Recruiting 2026-07-07
NCT06831370 A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults… Hodgkin Lymphoma Recruiting 2026-02-23
NCT07794735 A Study of TAK-664 in People With Primary Immunodeficiency Diseases Who Have Not Yet Been… Primary Immunodeficiency Diseases (PID) Not Yet Recruiting 2026-08-31
NCT04809363 A Study of CDPATH™ to Help Manage and Treat Crohn's Disease Crohn's Disease Active, Not Recruiting 2026-07-23
Phase 3
NCT07204314 A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive Disorder Major Depressive Disorder Recruiting 2026-09-02
NCT07623161 A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… Myelofibrosis Recruiting 2026-08-24
NCT06499285 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk… Myelodysplastic Syndromes Recruiting 2026-08-21
NCT06948318 A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia Immune Thrombocytopenic Purpura (ITP) Recruiting 2026-08-14
NCT06963827 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy Kidney Disease Recruiting 2026-08-14
NCT06671483 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic… Psoriatic Arthritis Recruiting 2026-08-11
NCT06671496 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been… Psoriatic Arthritis Recruiting 2026-08-11
NCT06722235 A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia Immune Thrombocytopenic Purpura (ITP) Recruiting 2026-08-07
NCT06980480 A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in… Multiple Myeloma Recruiting 2026-08-07
NCT07217301 A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer IO-resistant sqNSCLC Recruiting 2026-08-04
NCT06100289 A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's… Ulcerative Colitis Recruiting 2026-08-03
NCT06443502 A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and… Pouchitis Recruiting 2026-08-03
NCT07286058 Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis Psoriatic Arthritis Recruiting 2026-08-03
NCT07422480 A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low… Myelodysplastic Syndrome Recruiting 2026-07-22
NCT07250802 A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis Plaque Psoriasis Recruiting 2026-07-21
NCT06665035 A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers Dengue Fever Recruiting 2026-06-29
NCT06973304 A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome Short Bowel Syndrome Recruiting 2026-06-24
See all 128 active Takeda trials with filters →

Disease areas by active trials, top 10 of 19

Crohn's Disease (16) · Ulcerative Colitis (11) · Non-Small Cell Lung Cancer (NSCLC) (7) · Colorectal Cancer (5) · Lung Cancer (5) · Hodgkin Lymphoma (4) · Multiple Myeloma (4) · Myelodysplastic Syndromes (MDS) (4) · Psoriasis (3) · Psoriatic Arthritis (3)

Get alerts when Takeda's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free